Abstract:Ethnopharmacological relevance: Xiaochaihutang (XCHT), a famous Chinese herbal formula which consists of seven Chinese herbs, has been used clinically in depressive disorders in China. Our previous studies have demonstrated that XCHT improved depressive-like behavior in several animal models of depression. However, therapeutic basis of XCHT on depression are challenging, due to the complex active constituents of XCHT and the unclear pharmacological mechanism of action. Materials and methods: To provide further insights into therapeutic basis of XCHT, the core in compatibility of XCHT on antidepressant therapy was assessed by the method of orthogonal array design. The comparative evaluations on antidepressant effects of XCHT and its core in compatibility were executed by tail suspension test (TST), forced swim test (FST), novelty suppressed feeding test (NSFT), reserpine-induced hypothermia and palpebral ptosis. Moreover, the potential mechanism was explored by investigating levels of monoamine neurotransmitters in hypothalamus and striatum and neurogenesis in hippocampus. Chemical profile of active constituents in plasma after oral administration of the core in compatibility of XCHT was revealed by ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Results: The results of orthogonal array design experiment showed that Huangqin (Radix scutellariae), Renshen (Ginseng) and Gancao (Radix glycyrrhizae), defined as HRG, might be the core in compatibility of XCHT on antidepressant therapy. In accordance with XCHT, oral administration of HRG for 15 days significantly reduced immobility duration in TST and FST without affecting locomotor activity. Both HRG and XCHT increased immobility latency in FST, decreased the latency in NSFT, reversed reserpine-induced hypothermia and palpebral ptosis. Moreover, both HRG and XCHT significantly increased levels of 5-HT and DA in hypothalamus. In addition, HRG could remarkably increase Ki-67 and doublecortin (DCX) positive cells in hippocampus. A total 25 active constituents in plasma, including 14 prototype components and 11 metabolites, were identified by UPLC-MS/MS after oral administration of HRG. Conclusion: The present results reveal that HRG is supposed to be the core in compatibility of XCHT on antidepressant therapy. In accordance with XCHT, HRG exerts significant antidepressant-like effects, which are likely attributed to regulating serotonergic and dopaminergic systems and increasing hippocampal neurogenesis. The constituents identified in plasma after oral administration of HRG may be the potential active ingredients for the treatment of depression.

Study on Absorption of Effective Antidepressant Components of Kaixin Powder by HPLC and GC-MS

Network Pharmacological Investigation into the Mechanism of Kaixinsan Powder for the Treatment of Depression.

Analysis of main constituents and mechanisms underlying antidepressant-like effects of Xiaochaihutang in mice

[Research progress on chemical constituents and pharmacological effects of Kaixin Powder and predictive analysis of its Q-markers]

Strategy for the Multi-Component Characterization and Quality Evaluation of Volatile Organic Components in Kaixin San by Correlating the Analysis by Headspace Gas Chromatography/ion Mobility Spectrometry and Headspace Gas Chromatography/mass Spectrometry.

LC-PDA-MS/MS Analysis and Anti-Depressant Study of Zhizi-Gancao-Chi Decoction

Identification and quantification of the major volatile constituents in antidepressant active fraction of xiaoyaosan by gas chromatography-mass spectrometry

Kai-Xin-San, a standardized traditional Chinese medicine formula, up-regulates the expressions of synaptic proteins on hippocampus of chronic mild stress induced depressive rats and primary cultured rat hippocampal neuron

New Insights into Effects of Kaixin Powder on Depression Via Lipid Metabolism Related Adiponectin Signaling Pathway

Study on Antidepressant Effect of the Active Components in Zhi-Zi-Hou-Pu Decoction

Pharmacokinetic study of precisely representative antidepressant, prokinetic, anti-inflammatory and anti-oxidative compounds from Fructus aurantii and Magnolia Bark

Clinical Curative Effects of Kaixin Powder on Depression with Mild or Moderate Degree

Pharmacokinetics-pharmacodynamics and tissue distribution analysis of Low Polar extract of Xiaoyao Powder combined with rat model of chronic unpredictable mild stress

Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse.

[Anti-depression targets and mechanism study of Kaixin San]

A Comparative Study of Serum Pharmacochemistry of Kai-Xin-San in Normal and AD Rats Using UPLC-LTQ-Orbitrap-MS

Efficacy of Chinese herbal formula Kai-Xin-San on rodent models of depression: A systematic review and meta-analysis

Liquid chromatography–mass spectrometry in‐depth analysis and in silico verification of the potential active ingredients of Baihe Dihuang decoction in vivo and in vitro

Effects of Kaixin Powder (开心散) on melatonin receptor expression and 125 I-Mel binding affinity in a rat model of depression

Saponin Components Analysis of Antidepressant Extract PnGL from Leaves of Panax Notoginseng

Simultaneous Determination of Eight Bioactive Constituents of Zhi-Zi-Hou-Po Decoction in Rat Plasma by Ultra High Performance Liquid Chromatography with Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study